Predilife S.A. (EPA:ALPRE)

Market Cap	11.79M -17.1%
Revenue (ttm)	728.08K +142.0%
Net Income	-3.80M
EPS	-1.00
Shares Out	3.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11
Average Volume	3,705
Open	3.110
Previous Close	3.120
Day's Range	3.110 - 3.120
52-Week Range	2.810 - 4.980
Beta	0.30
RSI	45.15
Earnings Date	Apr 14, 2026

About Predilife

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2004
• Employees: 27
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALPRE

Financial Performance

In 2024, Predilife's revenue was 493,202, an increase of 55.20% compared to the previous year's 317,794. Losses were -4.26 million, 0.96% more than in 2023.